103 related articles for article (PubMed ID: 28534940)
1. The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain.
Perumal V; Dharmarajan AM; Fox SA
Int J Oncol; 2017 Jul; 51(1):362-368. PubMed ID: 28534940
[TBL] [Abstract][Full Text] [Related]
2. Number and brightness analysis of sFRP4 domains in live cells demonstrates vesicle association signal of the NLD domain and dynamic intracellular responses to Wnt3a.
Perumal V; Krishnan K; Gratton E; Dharmarajan AM; Fox SA
Int J Biochem Cell Biol; 2015 Jul; 64():91-6. PubMed ID: 25805505
[TBL] [Abstract][Full Text] [Related]
3. Netrin-like domain of sFRP4, a Wnt antagonist inhibits stemness, metastatic and invasive properties by specifically blocking MMP-2 in cancer stem cells from human glioma cell line U87MG.
Yasmin IA; Mohana Sundaram S; Banerjee A; Varier L; Dharmarajan A; Warrier S
Exp Cell Res; 2021 Dec; 409(2):112912. PubMed ID: 34762897
[TBL] [Abstract][Full Text] [Related]
4. The role of the cysteine-rich domain and netrin-like domain of secreted frizzled-related protein 4 in angiogenesis inhibition in vitro.
Longman D; Arfuso F; Viola HM; Hool LC; Dharmarajan AM
Oncol Res; 2012; 20(1):1-6. PubMed ID: 23035359
[TBL] [Abstract][Full Text] [Related]
5. Delivery of expression constructs of secreted frizzled-related protein 4 and its domains by chitosan-dextran sulfate nanoparticles enhances their expression and anti-cancer effects.
Perumal V; Arfuso F; Chen Y; Fox S; Dharmarajan AM
Mol Cell Biochem; 2018 Jun; 443(1-2):205-213. PubMed ID: 29185158
[TBL] [Abstract][Full Text] [Related]
6. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
He B; Lee AY; Dadfarmay S; You L; Xu Z; Reguart N; Mazieres J; Mikami I; McCormick F; Jablons DM
Cancer Res; 2005 Feb; 65(3):743-8. PubMed ID: 15705870
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells.
Perumal V; Pohl S; Keane KN; Arfuso F; Newsholme P; Fox S; Dharmarajan A
Exp Cell Res; 2016 Feb; 341(2):218-24. PubMed ID: 26868304
[TBL] [Abstract][Full Text] [Related]
8. Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells.
Fox SA; Richards AK; Kusumah I; Perumal V; Bolitho EM; Mutsaers SE; Dharmarajan AM
Biochem Biophys Res Commun; 2013 Oct; 440(1):82-7. PubMed ID: 24041698
[TBL] [Abstract][Full Text] [Related]
9. Demethylation of the
Li H; Zhao J; Sun J; Tian C; Jiang Q; Ding C; Gan Q; Shu P; Wang X; Qin J; Sun Y
Mol Cancer Res; 2021 Sep; 19(9):1454-1464. PubMed ID: 34016745
[TBL] [Abstract][Full Text] [Related]
10. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells.
Carmon KS; Loose DS
Mol Cancer Res; 2008 Jun; 6(6):1017-28. PubMed ID: 18567805
[TBL] [Abstract][Full Text] [Related]
11. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma.
Lee AY; He B; You L; Dadfarmay S; Xu Z; Mazieres J; Mikami I; McCormick F; Jablons DM
Oncogene; 2004 Aug; 23(39):6672-6. PubMed ID: 15221014
[TBL] [Abstract][Full Text] [Related]
12. Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy.
Ghoshal A; Ghosh SS
Mol Cell Biochem; 2016 Jul; 418(1-2):119-35. PubMed ID: 27334754
[TBL] [Abstract][Full Text] [Related]
13. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
[TBL] [Abstract][Full Text] [Related]
14. Placental expression of secreted frizzled related protein-4 in the rat and the impact of glucocorticoid-induced fetal and placental growth restriction.
Hewitt DP; Mark PJ; Dharmarajan AM; Waddell BJ
Biol Reprod; 2006 Jul; 75(1):75-81. PubMed ID: 16540541
[TBL] [Abstract][Full Text] [Related]
15. Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.
Horvath LG; Henshall SM; Kench JG; Saunders DN; Lee CS; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
Clin Cancer Res; 2004 Jan; 10(2):615-25. PubMed ID: 14760084
[TBL] [Abstract][Full Text] [Related]
16. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract][Full Text] [Related]
17. Short peptide domains of the Wnt inhibitor sFRP4 target ovarian cancer stem cells by neutralizing the Wnt β-catenin pathway, disrupting the interaction between β-catenin and CD24 and suppressing autophagy.
Sundaram SM; Varier L; Fathima KZ; Dharmarajan A; Warrier S
Life Sci; 2023 Mar; 316():121384. PubMed ID: 36646377
[TBL] [Abstract][Full Text] [Related]
18. Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma.
Lee AY; He B; You L; Xu Z; Mazieres J; Reguart N; Mikami I; Batra S; Jablons DM
Biochem Biophys Res Commun; 2004 Oct; 323(4):1246-50. PubMed ID: 15451431
[TBL] [Abstract][Full Text] [Related]
19. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis.
Pohl S; Scott R; Arfuso F; Perumal V; Dharmarajan A
Tumour Biol; 2015 Jan; 36(1):143-52. PubMed ID: 25501511
[TBL] [Abstract][Full Text] [Related]
20. MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats.
Miao CG; Huang C; Huang Y; Yang YY; He X; Zhang L; Lv XW; Jin Y; Li J
Cell Signal; 2013 Mar; 25(3):598-608. PubMed ID: 23200852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
